Insight Molecular Diagnostics Inc. is rated Hold due to upcoming catalysts & pending FDA submission for GraftAssureDx. Read ...

The global medical device outsourcing market size is projected to reach USD 386.08 billion by 2033, growing at a CAGR of ...

Given the amount of tests that have required certification under the new system, the EU has staggered the grace periods for different classes of devices already holding CE-IVD marks obtained under the ...

What does it take to get into the medical device industry? Sometimes it takes just a pinch of audacity. Lishan Aklog, MD, ...

Tempus AI advances its genomics push with new assays, CDx progress and plans for whole-genome sequencing to drive future growth.

Parminder Kalle to lead IMed’s new chapter of international growth Oxford, 12 November 2025 – IMed Group, a leading provider ...

The U.S. blood-based biomarker market for Alzheimer's diagnostics is poised for significant growth, driven by rising Alzheimer's prevalence, non-invasive diagnostic demand, and FDA-approved assays ...

On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...

ABL Diagnostics (Euronext Paris: ABLD), a French company specializing in advanced molecular diagnostics, announces the signing of an exclusive distribution agreement with Eurobio Scientific (Euronext ...

The bone health supplements market is witnessing steady adoption across pharmaceutical companies, nutraceutical manufacturers, healthcare providers, and ...

Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix ®), a life sciences innovator, manufacturer, and exporter, and SEKISUI Diagnostics, LLC (SEKISUI ), a global manufacturer of innovative ...

Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases by developing ...